Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose vs. low‐dose heparin protocols
| Autor: | Andreas Hanslik, M. Haumer, Christoph Male, Katharina Thom, Ina Michel-Behnke, Erwin Kitzmüller, W. Mlekusch, Ulrike Salzer-Muhar |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Male
Cardiac Catheterization medicine.medical_specialty Randomization medicine.medical_treatment Blood Loss Surgical law.invention Bolus (medicine) Double-Blind Method Randomized controlled trial law Humans Medicine Cardiac catheterization Dose-Response Relationship Drug Heparin business.industry Incidence Infant Thrombosis Hematology medicine.disease Surgery Child Preschool Anesthesia Relative risk Cohort Female business Cohort study |
| Zdroj: | Journal of Thrombosis and Haemostasis. 9:2353-2360 |
| ISSN: | 1538-7836 |
| DOI: | 10.1111/j.1538-7836.2011.04539.x |
| Popis: | Summary. Background: During cardiac catheterization (CC) in children, unfractionated heparin (UFH) is used for primary prophylaxis of thrombotic events (TE). However, the optimal UFH dose to minimize TE and bleeding in children has yet to be established. Objectives: To (i) objectively assess the incidence of TE and bleeding during pediatric CC using clinical assessment and ultrasound; and (ii) compare a high-dose vs. low-dose UFH protocol for thromboprophylaxis. Methods: A randomized controlled trial (RCT) comparing high-dose UFH (100 units kg−1 bolus, followed by 20 units kg h−1 continuous infusion) vs. low-dose UFH (50 units kg−1 bolus) during CC. Outcome assessment was by clinical examination and vascular ultrasound, performed by blinded examiners before and within 48 h after CC. Children with no consent for randomization were followed in a cohort receiving standard-of-care UFH (parallel-cohort RCT). Results: A total of 227 children were included; 137 were randomized and 90 followed in the cohort study. The overall incidence of TE was 4.6% and bleeding 6.6%. The RCT was stopped early for futility as there were no differences between the high-dose and the low-dose UFH in TE (5% vs. 3%; risk ratios [RR] 1.5, 95% confidence interval [CI] 0.3; 9) and bleeding (7% vs. 12%, RR 0.6, 95% CI 0.2; 2). There were also no differences when RCT and cohort study populations were combined. Conclusions: The incidences of TE and bleeding during CC in children were low. There were no differences between the high-dose and the low-dose UFH protocols studied. Although Heparin Anticoagulation Randomized Trial in Cardiac Catheterization (HEARTCAT) was not designed as non-inferiority trial, low-dose UFH (50 units kg−1 bolus) appears sufficient for thromboprophylaxis during CC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text